Skip to main content
OpenTrials
Completed

NCT Number: NCT00724919

A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, post- intervention in the selected medical centres

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infection Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Miaoli County, Taiwan

Loading trial locations.

About this study

This is post-interventional study to follow the acquisition rate of ESBP producing E. coli or K. pneumoniae at the sites involved in a previous interventional study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion

  • All patients admitted or transferred to ICU/burn unit.
  • Patients of either sex, 18 years of age or older. Exclusion

Patients were excluded if they had underlying conditions or diseases that were ultimately fatal within 48 hours

Treatment and study plan

Primary outcomes

  1. The acquisition rate of ESBL producing E. coli or K. pneumoniae at the end of surveillance phase

    Time frame: 48hours

Secondary outcomes

  1. The infection rate due to ESBL producing E. coli, or due to K. pneumoniae at the end of surveillance phase

    Time frame: 48hours

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Association of Antibiotic Utilization Measures and Control of Extended-Spectrum β-Lactamases (ESBLs) (A Post-Intervention Surveillance Study)

Important dates

Study start
2003
Primary completion
2004
Study completion
2004
First posted
Jul 30, 2008
Registry last updated
Aug 11, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.